What government contracts does The Institute for Cancer Research hold?
The Institute for Cancer Research holds 4 government contract awards worth $5.3M on RFPFinder, most from National Institutes of Health (4 awards), mainly under NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN12. 3 of them end in the next 12 months. The latest award on record is dated Jul 10, 2023.
Recent awards
4 awards, newest first| Awarded | Agency | Description | Amount | Source record |
|---|---|---|---|---|
| Jul 10, 2023 | National Institutes of Health | COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS75N91023F00001 | $1.0M | Source |
| Sep 15, 2022 | National Institutes of Health | TASK ORDER TITLE: MICROBIAL METABOLITE MIMICRY, A NANO-DRUG FOR COLON CANCER PREVENTION PREVENT PRECLINICAL DRUG DEVELO…75N91022F00003 | $948K | Source |
| Jun 15, 2022 | National Institutes of Health | BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS TASK…75N91022F00001 | $2.1M | Source |
| May 18, 2022 | National Institutes of Health | TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER75N91022F00002 | $1.2M | Source |
Contracts ending in the next 12 months
3 awards by period-of-performance end| Ends | Agency | Description | Amount | Source record |
|---|---|---|---|---|
| Nov 17, 2026 | National Institutes of Health | TASK ORDER TITLE: NEXT GENERATION GP130/IL-6/STAT3 INHIBITORS FOR THE PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER75N91022F00002 | $1.2M | Source |
| May 14, 2027 | National Institutes of Health | BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS TASK…75N91022F00001 | $2.1M | Source |
| Jul 9, 2027 | National Institutes of Health | COLORECTAL CANCER (CRC) PREVENTION BY UROLITHIN A IN RODENT CRC MODELS75N91023F00001 | $1.0M | Source |
Open solicitations The Institute for Cancer Research could bid on
Open notices under PSC AN12, The Institute for Cancer Research's most frequent product and service code, soonest deadline first.
Questions about The Institute for Cancer Research
What does The Institute for Cancer Research sell to the government?
The Institute for Cancer Research's awards on RFPFinder fall mostly under NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN12. Its most common product and service code is AN12, on 4 awards.
Which agencies buy from The Institute for Cancer Research?
National Institutes of Health (4 awards) is the buyer from The Institute for Cancer Research on RFPFinder, out of 1 agency in total.
How much has The Institute for Cancer Research been awarded in government contracts?
$5.3M across 4 awards on RFPFinder, May 2022 to July 2023. That is the sum of the award records RFPFinder holds, not a complete history of The Institute for Cancer Research's government revenue.
How do I find The Institute for Cancer Research's UEI or CAGE code?
The Institute for Cancer Research's UEI on its federal awards is FF1XVJMDYVR1. Award records do not carry CAGE codes; search the UEI in SAM.gov's entity search to see the CAGE code and registration status.
Vendor totals add up the award records RFPFinder holds: federal contract awards from USAspending.gov for the agencies and codes behind open notices, and state and local awards from open-data contract registers and purchase-order files. They are not a vendor's complete government revenue, and a register that lists a contract ceiling or repeats a contract can overstate spend. Names are grouped across spellings ("Corp" and "Corporation"); each award links to its source record. Subcontracts are prime contractors' subaward reports on USAspending.gov for the prime awards behind the same agencies and codes, and GSA Schedule contracts come from GSA eLibrary's MAS contractor list; both are matched to vendors by name.